Clinical Trials Browser

Phase 2 × INDUSTRY × peginterferon alfa-2b × Clear all

NCT02155322 2018-08-23

A Phase II Study of Pegylated Interferon Alfa-2b for the Adjuvant Treatment of Melanoma Subjects in Russia (MK-4031-400)

Phase 2 Completed

33 enrolled 7 charts

Melanoma